Saving changes...

Done

Error

Current radiotherapy practices for glioblastoma and possible future direction

Current radiotherapy practices for glioblastoma and possible future direction

Current radiotherapy practices for glioblastoma and possible future direction

Veterinary Cancer Society
Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

$FREE $ FREE $ FREE

$ FREE $ FREE $ FREE
$ 25.00 $ 25.00 $ 25.00
Normal Price: FREE $25.00

Review:

Launch date: 14 Jan 2016

Expiry Date:

Last updated: 20 Apr 2016

Reference: 161839

Exam is embedded in the course
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

“Current radiotherapy practices for Glioblastoma and possible future direction” His talk will review the current radiotherapy trends for GBM therapy and will discuss laboratory and translational research that may change practice in the future.

Objectives

Learning Objectives
• Attendees will understand the preclinical and clinical development of radiosensitizers
• Attendees will understand how novel “omics” platforms can are utilized in cancer research/therapy
• Attendees will understand tumor and therapeutic biomarkers
Veterinary Cancer Society

Author Information Play Video Bio

Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

Dr. Kevin Camphausen
Radiation Oncology Branch
National Cancer Institute
National Institutes of HealthKevin Camphausen received his undergraduate degree from Purdue University in 1988.  He then completed his MD (1996) and medical internship (1997) at Georgetown University Medical Center.  He next completed his residency in radiation oncology at the Joint Center of Radiation Therapy at Harvard Medical School (2001).  While there, he worked in the laboratory of Dr. Judah Folkman studying the interactions of antiangiogenic therapy and radiotherapy.  He joined the Radiation Oncology Branch in 2001 as a tenure track investigator, received tenure in 2007 and was promoted to Chief of the Radiation Oncology Branch (ROB), Center for Cancer Research (CCR), NCI.  He is a physician/scientist who has a laboratory program focusing on the development and characterization of agents that alter the tumoral response to radiation.  He has been successful in translating his work from the laboratory to the clinic. Dr. Camphausen is an internationally recognized leader in his field and an expert in the field of drug-induced tumor radiosensitization including the use of anti-angiogenic agents in combination with radiotherapy."

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Missouri Veterinary Medical Association
  • 0.25 Hours -
    Exam Attempts: 3
    -
    Exam Pass Rate: 50

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error